Accelerating enrollment with innovative expertise in gastrointestinal trials

Across every indication within the gastrointestinal therapeutic area, patients face varying challenges—and therapies offer a variety of support. Effective patient recruitment requires expert knowledge and a personalized approach to meet the challenges patients face. 

1nHealth takes full ownership of the enrollment process across this complex therapeutic area—making patient recruitment one less challenge for your next study.

0

Patients enrolled

0

Studies completed

0

Sites coordinated

Our​ difference​

Successful recruitment requires ​​ expertise and specialization at every stage of enrollment​

Gastrointestinal diseases encompass a broad spectrum of disorders, ranging from irritable bowel syndrome to colon cancer.

Gastrointestinal clinical trials are competitive and include large volumes of patient populations. For some indications, the need to identify and enroll patients in flare can create a bottleneck in recruitment. 

For clinical trial sponsors who refuse to settle for enrollment delays and inefficiencies, 1nHealth resets the standard. 

We don’t just promise, we deliver—so that you can focus on groundbreaking gastrointestinal research and treatments.

Partnering with 1nHealth means embracing a future where patient recruitment is no longer a hurdle but a catalyst for success

Our expertise

Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder affecting 5–10% of the global population, with higher prevalence in women and individuals under 50. 

Characterized by abdominal pain, bloating, and altered bowel habits (constipation, diarrhea, or both), IBS significantly impairs quality of life. Its multifactorial etiology includes gut-brain axis dysregulation, visceral hypersensitivity, microbiome imbalances, and psychological stress.

Despite its prevalence, diagnosis is often delayed due to symptom overlap with other GI conditions.

Crohn's Disease

Crohn’s disease is a type of chronic inflammatory bowel disease (IBD), affecting approximately 1.6 million people globally, with increasing incidence in industrialized nations. 

It can involve any part of the gastrointestinal tract, most commonly the terminal ileum and colon. Characterized by relapsing inflammation, symptoms include abdominal pain, diarrhea (often bloody), fatigue, and weight loss. Complications such as strictures, fistulas, and malabsorption are common. 

The disease’s pathogenesis involves genetic predisposition, immune dysregulation, and environmental factors, including microbiome imbalances.

Colon Cancer

Colorectal cancer (CRC), the third most common cancer globally, accounts for over 1.9 million new cases and 935,000 deaths annually. 

Primarily affecting individuals over 50, its incidence is rising among younger adults. Risk factors include a family history of CRC, inflammatory bowel disease, obesity, smoking, and diets high in red or processed meats. 

Symptoms such as rectal bleeding, altered bowel habits, and unexplained weight loss often emerge in advanced stages, highlighting the importance of screening.

Our​ success​

“1nHealth’s expertise in digital recruitment played a pivotal role... ensuring the process was efficient and reflective of real-world conditions.”​

Chief Executive Officer​

Colon Cancer Screening

Learn how 1nHealth leveraged the support of online consent processes and live call center support to enroll more than 2,500 participants in a colon cancer screening procedure.
View Case Study

Shingles Vaccine

How close collaboration between 1nHealth and site staff led to faster enrollment than even the best-case timeline projections for a shingles vaccine campaign.

Hover to reveal top creative

Type 2 Diabetes

Learn how 1nHealth enrolled 98 patients from the U.S. and Europe with hands-on site support provided by 1nData’s study platform capabilities.
View Case Study

Basket Study | Underrepresented Patients

Learn how 1nHealth enrolled a nationwide study in the United States with patients representing non-Caucasian genome (Black, Latino, Asian, MENA, NHPI, Native American).
View Case Study

Breast Cancer Chemo Fatigue

Learn how 1nHealth optimized top-of-funnel digital recruitment strategies to improve down-funnel enrollment and rescued a virtual study targeting breast cancer survivors suffering from chemo fatigue.

Hover to reveal top creative

Our experience across other therapeutic areas

Your next trial is thoughtful, complex, and different. Your patient recruitment should be too.

From kick-off to last patient in, 1nHealth builds a reliable source of referred enrollments through proven recruitment programs and high-touch patient engagement.

Click each area to learn more.​

Reach LPI more quickly in your next gastrointestinal trial with expert recruitment and enrollment.